Barbara Janota

Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC-99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma

Anna Sowa‐Staszczak, Dorota Pach, Renata Mikołajczak et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2012 · 119 citations · Full text

Medicine, Endocrinology, Radiology +17

99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years’ experience

Alicja Hubalewska–Dydejczyk, Katarzyna Fröss‐Baron, Renata Mikołajczak et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2006 · 111 citations

Medicine, Nuclear Medicine, Radiology +17

Radiopharmaceutical development of a freeze-dried kit formulation for the preparation of [99mTc-EDDA-HYNIC-D-Phe1, Tyr3]-octreotide, a somatostatin analog for tumor diagnosis

Elisabeth von Guggenberg, Renata Mikołajczak, Barbara Janota et al. · Journal of Pharmaceutical Sciences · 2004 · 45 citations

Medicine, Nuclear Medicine, Oncology +17

99mTc Labeled Glucagon-Like Peptide-1-Analogue (99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma

Anna Sowa‐Staszczak, Małgorzata Trofimiuk–Müldner, Agnieszka Stefańska et al. · PLoS ONE · 2016 · 41 citations · Full text

Medicine, Endocrinology, Surgery +17

[99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes

Berthold A. Nock, Aikaterini Kaloudi, Panagiotis Kanellopoulos et al. · Cancers · 2021 · 35 citations · Full text

Medicine, Nuclear Medicine, Oncology +17